CCNE2 and non-small cell lung carcinoma: In conclusion, this study suggests that loss of TP53 activates uc.339 as an oncogene in NSCLC by entrapping miR-339, -663b, and -95, and preventing their targeting of oncogenic CCNE2, leading to increased tumor growth and migration.